Rune has several other products in development including a general technology that revolutionizes drug delivery.
These include:
A Neurology Portfolio
Including treatments for Chronic Neurodegenerative Disorders such as Huntington’s Chorea, and treatments for more acute onset Neurological disorders.
A Pain Portfolio
Many conditions result in pain, Rune has targeted pain treatments and more general pain therapy options in development.
A NeuroPsychiatry Portfolio
Tourette’s and rare epilepsies represent other challenges to clinicians as treatment options are often untested, resulting in therapeutic options tending to be off-label use of existing products indicated and tested for other conditions. Rune has a range of other options for some of these conditions too.
